Equities Fall Intraday After Fed Chair Powell's Comments
Sector Update: Health Care
US Equity Indexes Mixed, Treasury Yields Rise in Midday Trading
CVS Health Gets Activist Push From Glenview Capital: WSJ
Top Midday Stories: AT&T Sells 70% DirecTV Ownership Stake to TPG; FTC Bars Hess CEO From Joining Chevron Board
CVS Stock Is the Best Performer in the S&P 500. An Activist Wants Changes. -- Barrons.com
Nasdaq, S&P, and Dow Tick Lower Ahead of Powell's Address
Great Week for CVS Health Corporation (NYSE:CVS) Institutional Investors After Losing 8.5% Over the Previous Year
U.S. stocks unusual movement: cvs health rose 2.2%, Hedge fund Glenview will meet with company executives to promote reform.
On September 30, Gelunhui | cvs health (CVS.US) rose by 2.2%, to $62.73. In terms of news, according to The Wall Street Journal, the hedge fund Glenview Capital Management, specializing in medical care, will meet with executives of cvs health on Monday to offer suggestions for improving operations. Currently, Glenview holds approximately 1% of cvs health's outstanding shares.
Sector Update: Health Care Stocks Steady Premarket Monday
After cvs health (CVS.US) repeatedly lowered profit guidance, a major shareholder Glenview will meet with executives to promote reform.
Media cited sources as saying that hedge fund Glenview Capital Management will meet with CVS Health executives on Monday to present suggestions for improving operations.
Express News | CVS Health Shares up 2% Premarket After Report Glenview to Meet Co's Top Execs, Propose Operational Improvements
Glenview Set to Meet CVS Health Top Exes to Drive Changes - Report
Hedge fund Glenview will meet with CVS executives to propose suggestions for improving operation.
According to The Wall Street Journal on September 30th, Glenview Capital Management, a hedge fund focused on medical care, will meet with executives of the struggling medical care company CVS Health on Monday to offer suggestions for improving operations. According to a source familiar with the matter, the founder of this hedge fund, Larry Robbins, has established a significant position in CVS, accounting for about 0.7 billion dollars in its 2.5 billion dollar hedge fund. CVS stated, "As part of our strong shareholders' and analysts' participation plan, the company regularly engages with the investment community."
Major CVS Shareholder Plans Activist Push, Will Meet With Management, Sources Say
Glenview Capital Plans Push for Changes at CVS -- WSJ
Shares of Pharmacy Stocks Are Trading Higher. Costco on Its Earnings Call Said Pharmacy Had the Strongest Sales Percentage Increase Within Ancillary Businesses, With a Double-digit Script Count Growth, Which Could Possibly Be Lifting the Sector.
CVS Health Corporation (CVS) Is Attracting Investor Attention: Here Is What You Should Know
Target's Underdog CEO Is Aiming for Another Bull's-eye as He Writes His Final Chapter
CVS Health (CVS) Ascends While Market Falls: Some Facts to Note